TACO‐BEL‐3: a feasibility study and a retrospective audit of diuretics for patients receiving blood transfusion at ten hospitals-Reference-Cited by-同舟云学术

TACO‐BEL‐3: a feasibility study and a retrospective audit of diuretics for patients receiving blood transfusion at ten hospitals

Published:2020-10-26 Issue:4 Volume:116 Page:434-439
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Khandelwal Aditi¹²³⁴,Lin Yulia¹⁴⁵^ORCID,Cserti‐Gazdewich Christine¹²⁴^ORCID,Al Moosawi Muntadhar⁶,Armali Chantal⁴⁵,Arnold Donald⁷⁸,Callum Jeannie²⁴,Dallas Karen L.⁶⁹,Lieberman Lani¹²⁴,Pavenski Katerina¹⁴¹⁰,Rioux‐Massé Benjamin¹¹,Shehata Nadine²³⁴¹²,Shih Andrew W.⁶¹³¹⁴,Pendergrast Jacob¹²⁴

Affiliation:

1. Department of Laboratory Medicine and Pathobiology University of Toronto Toronto ON Canada

2. Laboratory Medicine Program University Health Network Toronto ON Canada

3. Canadian Blood Services Toronto ON Canada

4. Education and Safety in Transfusion (QUEST) Research Program University of Toronto Quality in Utilization Toronto ON Canada

5. Sunnybrook Health Sciences Centre Toronto ON Canada

6. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver BC Canada

7. Hamilton General Hospital Hamilton ON Canada

8. Juravinski Cancer Centre Hamilton ON Canada

9. St. Paul Hospital Vancouver BC Canada

10. St Michael’s Hospital Toronto ON Canada

11. Centre Hospitalier de l’Université de Montréal Montreal PQ Canada

12. Mount Sinai Hospital Toronto ON Canada

13. Vancouver General Hospital Vancouver BC Canada

14. Centre for Blood Research University of British Columbia Vancouver BC Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.12994

Reference21 articles.

1. Public Health Agency of Canada:Health Canada Transfusion Transmitted Injuries Surveillance System 2006–2012 Report. Vol. 2016 2014.http://www.phac‐aspc.gc.ca/hcai‐iamss/ttiss‐ssit/index‐eng.php

2. FDA Center for Biologics Evaluation & Research. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2017.2020. Retrieved fromhttps://www.fda.gov/media/124796/download. February 9

3. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion‐associated circulatory overload;Lieberma L;Transfus Med Rev,2013

4. The Prevention of Transfusion-Associated Circulatory Overload

5. Risk factors and clinical outcomes associated with perioperative transfusion‐associated circulatory overload;Clifford L;Anesthesiology,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How I Treat Anemia with Red Blood Cell Transfusion and Iron;Blood;2022-10-31

2. The recipe for TACO: A narrative review on the pathophysiology and potential mitigation strategies of transfusion-associated circulatory overload;Blood Reviews;2022-03

3. Active surveillance of serious adverse events following transfusion of COVID ‐19 convalescent plasma;Transfusion;2021-10-22